Work

Reduced Intra-individual Reaction Time Variability During a Go–NoGo Task in Detoxified Alcohol-Dependent Patients After One Right-Sided Dorsolateral Prefrontal HF-rTMS Session

Year: 2013
Type: article
Study design: Clinical Trial
Abstract: AIMS: As alcohol dependency is characterized by severe executive function deficits, we examined the influence of high-frequency (HF) repetitive transcranial magnetic stimulation (rTMS) applied to the right dorsolateral prefrontal cortex (DLPFC) on executive functioning in recently detoxified alcohol-dependent patients. METHODS: In this randomized, single blind, sham (placebo)-controlled, crossover study, we included 50 detoxified alcohol-dependent patients. We examined the effect of a single right DLPFC HF-rTMS session on commission errors, mean reaction times (RTs) and intra-individual reaction time variability (IIRTV) during a Go-NoGo task (50% Go/50% NoGo condition) in 29 alcohol-dependent patients. Patients completed this cognitive task immediately before and immediately after the stimulation session. In order to avoid carry-over effects between stimulation sessions, a 1-week inter-session interval was respected. Because rTMS treatment has been shown to affect subjective craving, all patients were also assessed with the Obsessive Compulsive Drinking Scale (OCDS). RESULTS: After both stimulation conditions, we observed a significant decrease of commission errors, without differences between active and sham HF-rTMS stimulation. No significant difference was observed between active and sham stimulation on mean RT. However, only active stimulation resulted in a significant decrease in IIRTV. No effects of stimulation were found for the craving measurements. CONCLUSION: Our findings suggest that in recently detoxified alcohol-dependent patients, one right-sided HF-rTMS session stabilizes cognitive performance during executive control tasks, implying that active stimulation reduces patients' proneness to attentional lapses.
Language: English
Subfield: Neurology
Open Access status: green
Funder: AstraZeneca
OpenAlex ID: W2107009792
FWCI: 2.504
Cites: 53
Cited by: 96
Related to: 10